Literature DB >> 3256650

Involving the patient in reporting adverse drug reactions.

J P Campbell, J G Howie.   

Abstract

A method is described for increasing the level of reporting of adverse drug reactions. Patients prescribed a black triangle drug (one being monitored by the Committee on Safety of Medicines) were given a leaflet by the dispensing chemists in one town, encouraging them to report any adverse reaction to their doctor. Over two two-month periods, reports of adverse reactions rose from six out of 576 in the control period (10 per 1000) to 11 out of 481 (23 per 1000) in the study period but only one 'yellow card' was submitted to the Committee on Safety of Medicines.

Entities:  

Mesh:

Year:  1988        PMID: 3256650      PMCID: PMC1711514     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  14 in total

1.  Demography of the UK adverse reactions register of spontaneous reports.

Authors:  C J Speirs; J P Griffin; J C Weber; M Glen-Bott
Journal:  Health Trends       Date:  1984-08

2.  Adverse-drug-reaction monitoring.

Authors:  G A Faich
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

3.  Postmarketing surveillance of adverse drug reactions: problems and solutions.

Authors:  F M Lortie
Journal:  CMAJ       Date:  1986-07-01       Impact factor: 8.262

4.  Prescription-event monitoring and yellow cards.

Authors:  W H Inman
Journal:  Lancet       Date:  1984-06-09       Impact factor: 79.321

5.  Prescription event monitoring.

Authors:  W H Inman
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

6.  Adverse drug reaction monitoring: doing it the French way.

Authors:  N Moore; M Biour; G Paux; E Loupi; B Begaud; F Boismare; R J Royer
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321

7.  Discovering adverse drug reactions.

Authors:  L Lasagna
Journal:  JAMA       Date:  1983 Apr 22-29       Impact factor: 56.272

8.  Adverse reactions to new drugs.

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-26

9.  Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15

10.  Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methods.

Authors:  A C Rossi; D E Knapp; C Anello; R T O'Neill; C F Graham; P S Mendelis; G R Stanley
Journal:  JAMA       Date:  1983 Apr 22-29       Impact factor: 56.272

View more
  3 in total

1.  Adverse drug reactions.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  1991-11

2.  Patient reporting of potential adverse drug reactions: a methodological study.

Authors:  N Jarernsiripornkul; J Krska; P A G Capps; R M E Richards; A Lee
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

3.  Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation.

Authors:  Daniel B Horton; Tobias Gerhard; Amy Davidow; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-08-31       Impact factor: 2.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.